Garza-Hinojosa A, González-Cordero G

Idioma: Español
Referencias bibliográficas: 30
Paginas: 257-262
Archivo PDF: 178.71 Kb.

FRAGMENTO

Introducción Durante la cesárea en mujeres sanas con anestesia regional se pueden observar cambios transitorios del electrocardiograma (ECG), tales como depresión del segmento ST y anormalidades de la onda T. Los cambios electrocardiográficos, similares a los observados en la isquemia miocárdica, junto con dolor torácico, son comunes durante la cesárea. Existe la teoría de que la administración de oxitocina provoca efectos cardiovasculares que hace que se presenten estos síntomas y cambios ECG.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Palmer CM, Norris MC, Giudici MC, et al. Incidence of electrocardiographic changes during caesarean delivery under regional anesthesia. Anesth Analg. 1990;70:36-43.

2. McLintic AJ, Pringle SD, Lilley S, et al. Electrocardiographic changes during caesarean section under regional anesthesia. Anesth Analg. 1992;74:51-56.

3. Mathew JP, Fleisher LA, Rinehouse JA, et al. ST segment depression during labor and delivery. Anesthesiology, 1992;77:635-641.

4. Zakowski MI, Ramanathan S, Baratta JB, et al. Electrocardiographic changes during caesarean section: a cause for concern? Anesth Analg. 1993;76:162-167.

5. Spence A. Oxytocin during caesarean section. Anaesthesia. 2002;57:722-723.

6. Bolton TJ, Randall K, Yentis SM. Effect on the confidential enquires into maternal deaths on the use of syntocinon at caesarean section in the UK. Anaesthesia. 2003;58:277-279.

7. Moran C, Ni Bhuinneain M, Geary M, et al. Myocardial ischaemia in normal patients undergoing elective caesarean section: a peripartum assessment. Anaesthesia. 2001;56:1051-1058.

8. Chilvers JP, Cooper G, Wilson M. Myocardial ischaemia complicating an elective caesarean section. Anaesthesia. 2003;58:822-823.

9. Johnstone M. The cardiovascular effects of oxytocic drugs. Br J Anaesth. 1972;44:826-833.

10. Frank E. An accurate, clinically practical system for spatial vectorcardiography. Circulation. 1956;13:737-749.

11. Jensen SM, Johansson G, Osterman G, et al. On-line computerized vectorcardiography monitoring of myocardial ischemia during coronary angioplasty: comparison with 12-lead electrocardiography. Coron Artery Dis. 1994;5:507-514.

12. Sederholm M, Erhardt L, Sjögren A. Continuous vectorcardiography in acute myocardial infarction. Natural course of ST and QRS vectors. Int J Cardiol. 1983;4:53-63.

13. Trotter TN, Langton JA, Barker P, et al. Perioperative continuous monitoring of ST-segment changes in patients undergoing elective caesarean section. Br J Anaesth. 1992;69:352-355.

14. Häggmark S, Haney MF, Johansson G, et al. ST-segment deviations during pacing-induced heart rate increased in patients without coronary artery disease. Clin Physiol Funct Imaging. 2005;25:246-252.

15. Ragnarsson, U. The Nobel trail of Vincent du Vigneaud. J Pept Sci. 2007;13:431-433.

16. Rall TW. Oxytocin, prostaglandins, ergot alkaloids, and other drugs; tocolytic agents. In: Goodman GA, Rall TW, Nies AS, Taylor P, eds. Goodman and Gillman’s The Pharmacological Basis of Therapeutics, 8th ed. New York: Pergamon Press. 1990. pp. 933-953.

17. Katz RL. Antiarrhythmic and cardiovascular effects of synthetic oxytocin. Anesthesiology. 1964;25:653-661.

18. Córdoba G, Pizzi R, Millán A, Levy A, Potella P. Usefulness of intramuscular oxytocin on the cesarean section. Bol Hosp Univ Caracas. 1993;23:40-42.

19. Thomas JS. Haemodynamic effects of oxytocin given as i.v. bolus or infusion on women undergoing Caesarean section. Br J Anaesth. 2007;98:116-119.

20. Fortner CL, Manley ES Jr, Woodbury RA. Effects of synthetic oxytocin with and without preservatives upon coronary blood flow in the dog. J Pharmacol Exp Ther. 1969;165:258-266.

21. Evron S, Ariely S, Agasi M, et al. Severe peripheral arteriospasm following oxytocin administration. Am J Obstet Gynecol. 1986;155:657-658.

22. Oliver MF. Ischaemic heart disease in young women. Br Med J. 1974;4:253-259.

23. Kulka PJ, Scheu C, Tryba M, et al. Myocardial infarction during pregnancy. Anaesthesist. 2001;50:280-284.

24. Thomas TA, Cooper GM. Anaesthesia. In: Lewis G. editor. Why Mothers Die 1997-1999: The confidential enquiry into maternal deaths in the United Kingdom. London: RCOG Press. 2001. pp. 135-137.

25. Nordström L, Fogelstam K, Fridman G, et al. Routine oxytocin in the third stage of labour: a placebo controlled randomized trial. Br J Obstet Gynaecol. 1997;104:781-786.

26. Thomas JS, Koh SH, Cooper GM. Haemodynamic effects of oxytocin given as i.v. bolus or infusion on women undergoing Caesarean section. Br J Anaesth. 2007;98:116-119.

27. Cotter A, Ness A, Tolosa J. Prophylactic oxytocin for the third stage of labour (Review). Cochrane Database Syst Rev. 2001; CD001808.

28. Carvalho JC, Balki M, Kingdom J, et al. Oxytocin requirements at elective caesarean delivery: a dose-finding study. Obstet Gynecol. 2004;104:1005-1010.

29. Robinson M, Newman N, Creevy DC, et al. Congenital aortic stenosis in pregnancy. Ventricular fibrillation induced by oxytocin. JAMA. 1967;5:378-381.

30. Svanström MC1, Biber B, Hanes M, Johansson G, Näslund U, Bålfors EM. Signs of myocardial ischaemia after injection of oxytocin: a randomized double-blind comparison of oxytocin and methylergometrine during Caesarean section. Br J Anaesth. 2008;100:683-689.